Sign in
Enrolling by invitationNo phase

Behavioral program to help teens with celiac disease manage a gluten-free diet

Tests a coaching program for teens with celiac disease and their parents.

Key facts

Who runs it
Children's National Research Institute
Where
Washington D.C., United StatesSee the site
Trial code
Registry title
Behavioral Intervention for Celiac Disease
Status
Enrolling by invitation
People taking part
96 people, planned
Started
7 Jun 2022
Planned end
1 Oct 2026
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • GROW Project
  • GROW+ Project
Record updated
11 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for teens with celiac disease and one parent or guardian. It tests online group sessions and text messages to help with the gluten-free diet.

Age
Teens 12-16 years at the time of enrollment.
Sex
All sexes can join.
Disease stage
Celiac disease confirmed by a doctor.

Main reasons for not taking part

  • The teen's celiac disease diagnosis is questioned or taken back during the study.
  • Another person in the household is already in the study.
  • The teen has a developmental disability or major brain-related condition that would make talking and taking part hard, in the view of the researchers.
  • Not able to read, write and speak English well.
  • No regular access to a device for Zoom video calls and text messages.

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Teens with a physician- confirmed CD diagnosis and one parent or guardian
  • Teens 12-16 years at the time of enrollment
  • Proficient in written and spoken English
  • Have regular access to a device enabled for video conferencing (Zoom) and receiving SMS messages

Who cannot take part

  • The teen has a developmental disability or major neuropsychological condition that, in the opinion of the investigators, would impair communication and engagement with the other participants and intervention material
  • The teen's CD diagnosis is questioned or revoked at any time during the study period
  • Another member of their household is already enrolled in the study

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 16 years old?

Where in United States

  • Children's National HospitalWashington D.C., United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Celiac disease (CD) is a chronic autoimmune condition whose only currently available treatment is a strict, burdensome gluten-free diet (GFD). The current proposal uses a theory-driven empirical approach for optimizing the GFD for teens and their parents by targeting knowledge, behavior, and coping skills through educational and cognitive-behavioral techniques. Integration with telehealth and SMS (short message service; "text") technology for delivering the intervention has the potential to reduce barriers to specialized treatment at both early and later stages of implementation. The proposed research will refine and test a behavioral intervention for teens with CD and their parents using an iterative stakeholder-centered design. It will consist of a small pilot randomized control trial (RCT) (n=96 dyads) that will examine the preliminary efficacy of the intervention and its impact on quality of life and GFD management by targeting self-efficacy, illness identity, and food-related activities. This work has the potential to make a lasting impact on the standards of care and available treatments to optimize CD management in youth and their families.

The 3 groups in the trial

  • GROW ProjectTreatment being tested

    ("GROW" Group): Live interactive telehealth-based group meetings will be held for 60 minutes per week over six weeks using Zoom for Telehealth, a HIPAA-compliant platform provided by the PI's institution. A teen group (n=8 per cohort) and a parent group (n=8 per cohort) will be run concurrently but separately, with coordinating topics. Each group meeting will introduce and facilitate discussion of information and CBT-oriented topics for coping and management of CD. Participants will be encouraged to use their audio and video to engage with the interventionist and each other. Between sessions, resources sent through text-based SMS messages using Twilio HIPAA-compliant software 3x/week as reminders of skills and goals for the week.

  • Care-As-UsualNo study treatment, for comparison

    Participants assigned to the control group (n=32 dyads) will receive care as usual, which consists of appointments in the Celiac Disease Clinic (at diagnosis, 3 months post-diagnosis, 6 months post-diagnosis, and annually after diagnosis thereafter). These appointments consist of a gastrointestinal physician or nurse practitioner, dietitian, GFD educator, and psychologist for 40-minute consultations each.

  • GROW+ ProjectTreatment being tested

    ("GROW+" Group): Will include the GROW Project with enhanced behavioral strategies and materials identified from phase 2 data (e.g., group discussion about GIP testing, text-based check-ins, etc.) In addition, teens in GROW+ will be encouraged to complete a minimum of 2 GlutenDetect tests per week (12 total) and report results in REDCap (Research Electronic Data Capture, a secure, web-based survey application) throughout the intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Testing a Behavioral Intervention in Pediatric Celiac Disease
Plain-language title
Behavioral program to help teens with celiac disease manage a gluten-free dietGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05204446, who can take part
Record updated
11 July 2025